ITH is a biotech investment company located at Karolinska Institutet and the Karolinska University Hospital dedicated to innovating the next generation of personalized therapeutics and diagnostics for patients with immune related diseases.

The company’s holding structure is organized to facilitate flexible and independent development of multiple innovations in parallel while maintaining synergies throughout the R&D portfolio with shared common services and expertise.